SCHEMBL7962335

SCHEMBL7962335

N#C/C(=C\c1cc(O)c(O)c(Br)c1)S(=O)(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.62
HPGD P15428 5/20 0.49
ALDH1A1 P00352 4/20 0.49
PKM P14618 3/20 0.49
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MEN1 O00255 2/20 0.49
ALOX15 P16050 2/20 0.49
ALOX12 P18054 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HSD17B10 Q99714 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
POLB P06746 2/20 0.49
GAA P10253 1/20 0.49
ALPG P10696 1/20 0.49
F2R P25116 1/20 0.43
PTGS2 P35354 2/20 0.38
PTGS1 P23219 1/20 0.38
NQO2 P16083 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7962340 1.00 EGFR (0.62) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL7962343 1.00 EGFR (0.62) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL9231430 0.88 EGFR (0.58) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL8323332 0.88 EGFR (0.58) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL8323329 0.88 EGFR (0.58) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL7952422 0.87 EGFR (0.66) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL7952426 0.87 EGFR (0.66) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL7952429 0.87 EGFR (0.66) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL7952731 0.87 IGF1R (0.54) EGFRHPGDALDH1A1PKMKMT2A
SCHEMBL7952727 0.87 IGF1R (0.54) EGFRHPGDALDH1A1PKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 WO disclosed